Ma ʻAmelika Hui Pū ʻIa, ma kahi o 17% o nā hihia Covid hou ma muli o ka ʻano EG.5, e like me nā helu mai ka US Centers for Disease Control and Prevention (CDC). ʻO ka ʻokoʻa EG he spinoff o ka XBB recombinant strain o ka ʻohana Omicron.

Ke hoʻohālikelike ʻia me kona makua XBB.1.9.2, loaʻa iā ia kahi hoʻololi hou i kona spike ma ke kūlana 465. Ua ʻike ʻia kēia hoʻololi ʻana i nā ʻano coronavirus ʻē aʻe ma mua. ʻAʻole maopopo ka poʻe ʻepekema i ke ʻano o nā hoʻopunipuni hou e hiki ai i ka maʻi ke hana, akā ke hoʻolohe nei nā mea hahai holoholona, no ka mea, ua lawe ka nui o nā mamo XBB hou iā ia.

Aia ka 465 mutation ma kahi o 35% o nā kaʻina coronavirus i hōʻike ʻia ma ka honua holoʻokoʻa, me kahi ʻē aʻe e piʻi aʻe nei i ka laha ma ka Northeast, FL.1.5.1, e hōʻike ana e lawe ana i kekahi ʻano o ka pono evolutionary ma mua o nā mana o mua. Loaʻa iā EG.5 kona ʻāpana ponoʻī, EG.5.1, e hoʻohui i kahi hoʻololi ʻelua i ka spike. Ke laha koke nei no hoi kela.

Ua hoʻāʻo ʻo Polofesa o Microbiology a me Immunology, ʻo Kauka David Ho, i kēia mau ʻano like ʻole i kāna lab ma Columbia University e ʻike i ke ʻano o ke kūpaʻa ʻana i nā antibodies e pono ai mākou e pale aku iā lākou. I loko o ka leka uila iā CNN, ua ʻōlelo ʻo ia, "ʻO nā mea ʻelua wale nō ke kūʻē i ka neutralizing antibodies i ka serum o ka maʻi a me ka maʻi. ua hōʻoia kanaka. ”

Ua ʻōlelo ʻo Kauka Eric Topol, he kauka maʻi ma ka Scripps Translational Research Institute, ʻaʻole ʻike ʻia kēia mau ʻano like ʻole i nā hōʻailona ʻokoʻa a i ʻole nā hōʻailona koʻikoʻi ma mua o nā maʻi i hiki mai ma mua o lākou.

"Loaʻa iā ia kekahi mau palekana palekana i hoʻohālikelike ʻia i nā mea i hana mua ʻia ma kēia ʻano XBB," wahi āna.

"He pōmaikaʻi ia, ʻo ia ke kumu e loaʻa ai nā wāwae a puni ka honua."

Ma waho aʻe o ka US, ke ulu wikiwiki nei ʻo EG.5 ma ʻIlelani, Palani, UK, Iapana, a me Kina. ʻO ka ʻO ka Hui Ola Ola (WHO) ua hoʻonui i kona kūlana i ka pule i hala aku nei mai kahi ʻokoʻa ma lalo o ka nānā ʻana i kahi ʻano hoihoi, kahi neʻe e hōʻailona ana i ka manaʻo o ke keʻena e pono ke nānā ʻia a aʻo hou ʻia.

Ua lilo ka ʻokoʻa i mea nui loa i ka US e like me nā hihia, nā kipa lumi pilikia, a me nā hale hoʻokipa e piʻi ana, ʻoiai ʻaʻohe mea e hōʻike ai ʻo kēia ʻano kikoʻī ka mea e hoʻonui ai i kēlā mau piʻi.

Akā, ke kuhikuhi nei nā epidemiologists i ke ʻano o ke kanaka ma ke ʻano he ʻenekini no kēia piʻi ʻana o ka hana. Ke kuhikuhi nei lākou i nā mea e like me ke kauwela - ʻoi aku ka nui o ka poʻe e noho ana i loko o ka hale no ka ea ea, huakaʻi e hoʻouna i nā poʻe ma waho o ko lākou mau pōʻai kaiaulu maʻamau, a ke hoʻi hou nei ke kula i kahi hālāwai kahi i kaulana ai nā maʻi maʻi no ka laha ʻana e like me ke ahi ahi.

Ua ʻōlelo ʻo Kauka Anne Hahn, kahi hui postdoctoral ma ke Keʻena ʻo Epidemiology of Microbial Diseases ma ke kula ʻo Yale School of Public Health, aia nā kumu e manaʻolana ai ʻaʻole e pōʻino loa kēia nalu o nā hihia Covid.

"Ke hoʻomaka nei mākou mai kahi haʻahaʻa haʻahaʻa i hui pū ʻia me ka nui o ka nui o ka lehulehu, e ʻōlelo kūʻē i kahi piʻi nui i kēlā me kēia manawa koke. Eia nō naʻe, ʻike ʻia ka mea e hana ai kēia mau ʻano hou i ka wā hoʻoilo, "wahi āna.

ʻO nā pae o ka maʻi maʻi i ʻike ʻia i loko o ka wai ʻōpala i ʻAukake e pili ana i ko lākou wahi i Malaki, e like me ka ʻikepili mai Biobot Analytics.

"Ke manaʻo nei au e loaʻa nā maʻi ākea, a ke manaʻo nei au e maʻalahi kēlā mau maʻi ākea," wahi a Kauka Dan Barouch, he immunologist a me ka virologist ma Harvard University ma Boston.

ka Nā manaʻo o WHO kū mau. e lapaau, uhi uhi, mālama i kahi mamao palekana, hoʻomaʻemaʻe, a inā ʻoe e hoʻāʻo i ka maikaʻi e hoʻokaʻawale iā ʻoe iho a hiki i ka maikaʻi ʻole.

He aha e lawe ʻia mai kēia ʻatikala:

The World Health Organization (WHO) upgraded its status last week from a variant under monitoring to a variant of interest, a move that signals the agency thinks it should be tracked and studied further.
Anne Hahn, a postdoctoral associate in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health says there are reasons to be hopeful this current wave of Covid cases won't be so bad.
The variant has become the most prevalent in the US just as cases, emergency room visits, and hospitalizations are going up, although there's nothing to suggest that this specific strain is what's driving those increases.